Current Report Filing (8-k)
April 17 2017 - 9:01AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of report (Date of earliest event reported):
April 17, 2017
Enzo Biochem, Inc.
(Exact Name of Registrant as Specified in Its
Charter)
New York
(State or Other Jurisdiction of Incorporation)
001-09974
|
13-2866202
|
(Commission File Number)
|
(IRS Employer Identification No.)
|
527 Madison Avenue
|
|
New York, New York
|
10022
|
(Address of Principal Executive Offices)
|
(Zip Code)
|
(212) 583-0100
(Registrant’s Telephone Number, Including
Area Code)
(Former Name or Former Address, if Changed Since
Last Report)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (
see
General Instruction
A.2. below):
o
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
o
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
o
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
o
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item
8.01 Other events
On April 17, 2017, Enzo Biochem, Inc. (the “Company”)
issued a press release titled “Enzo Biochem’s Clinical Laboratory Named an In-Network Provider to the Fourth Largest
National Insurer”.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
99.1
|
Press Release of Enzo Biochem, Inc., dated April 17, 2017.
|
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
ENZO BIOCHEM, INC.
|
|
|
|
|
|
Date: April 17, 2017
|
By:
|
/s/ Barry W. Weiner
|
|
|
|
Barry W. Weiner
|
|
|
|
President
|
|
Enzo Biochem (NYSE:ENZ)
Historical Stock Chart
From Aug 2024 to Sep 2024
Enzo Biochem (NYSE:ENZ)
Historical Stock Chart
From Sep 2023 to Sep 2024